Targeting SRC Family Kinases in Mesothelioma: Time to Upgrade
<b>A</b><b>bstract: </b>Malignant mesothelioma (MM) is a deadly tumor mainly caused by exposure to asbestos. Unfortunately, no current treatment is able to change significantly the natural history of the disease, which has a poor prognosis in the majority of patients. The non...
Main Authors: | Paola Indovina, Iris Maria Forte, Francesca Pentimalli, Antonio Giordano |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/7/1866 |
Similar Items
-
Platelet Src family kinases: A tale of reversible phosphorylation
by: Yotis A. Senis, et al.
Published: (2021-03-01) -
The Role of Hypoxia and SRC Tyrosine Kinase in Glioblastoma Invasiveness and Radioresistance
by: Filippo Torrisi, et al.
Published: (2020-10-01) -
<b>SRC Kinase in Glioblastoma News from an Old Acquaintance</b>
by: Claudia Cirotti, et al.
Published: (2020-06-01) -
Treatment of Recurrent Intracranial Hemangiopericytoma with SRC-Related Tyrosine Kinase Targeted Therapy: A Case Report
by: Katherine B. Peters, et al.
Published: (2010-04-01) -
Src kinase and Androgen Receptor in Prostate Cancer
by: Saxena, Parmita
Published: (2010)